# Element Biosciences
> Element Biosciences develops and commercializes innovative sequencing and multiomic platforms, including VITARI and AVITI24, powered by proprietary Avidite Base Chemistry (ABC Sequencing). Their platforms aim to provide high-quality, scalable, and affordable solutions for spatial, single-cell multiomics, and genomic research, streamlining workflows and accelerating discovery.
- URL: https://optimly.ai/brand/element-biosciences
- Logo: https://logo.clearbit.com/https://www.elementbiosciences.com/
- Slug: element-biosciences
- BAI Score: 48/100
- Archetype: Challenger
- Category: Biotechnology
- Last Analyzed: July 26, 2026
## Buyer Intent Signals
Problems: Traditional Lab Workflows: Researchers would rely on more fragmented and labor-intensive manual processes for library preparation, sample splitting, and integrating data from disparate 'omics platform | Contract Research Organizations (CROs) / Sequencing Service Labs: Instead of investing in an in-house Element Biosciences platform, researchers could outsource their sequencing and multiomics analysis | Continue with Existing Methods: Labs might continue using their current sequencing and multiomics equipment and methodologies. This option means foregoing the potential cost savings, scalability, impr
Solutions: Element Biosciences sequencing platform | AVITI24 multiomics system | Direct In Sample Sequencing DISS | Affordable genomic research tools | Avidite Base Chemistry technology | Separate 'Omics Platforms: Researchers might use distinct instruments and workflows for genomic sequencing, RNA sequencing, protein analysis, and cell morphology studies, then attempt to integrate the